DOD Announces Additional FY2008 Vision Research Funding; Pre-Application Deadlines Range from September 22 to October 1
September 18, 2008
The Department of Defense (DOD) has posted an announcement of a second round of potential Fiscal Year (FY) 2008 research funding within its Congressionally Directed Medical Research Program (CDMRP). The Deployment Related Medical Research Program (DRMRP) is $92 million pool of funds created by the mid-year Supplemental Appropriations Act (which also increased National Institutes of Health funding by $150 million) for research into the prevention, diagnosis, treatment, and mitigation of deployment-related injuries, including visual/ocular trauma treatment and rehabilitation, traumatic brain injury (TBI), and wound infection. The DRMRP has three award mechanisms—Hypothesis Development Award, Advanced Technology/Therapeutic Award, and Clinical Trial Award. The Advanced Technology Award specifically requests research into prevention and treatment of penetrating eye injuries, approaches to repair retinal damage, and low vision rehabilitation techniques and vision augmentation technologies.
NAEVR Advocacy Manager David Epstein with Col. Robert Mazzoli, M.D., Chief of Ophthalmology at Madigan Army Medical Center, at the Schepens Symposium on Military Eye Trauma
Pre-application deadlines are as early as September 22 (Hypothesis Award) to October 1, with proposals required by October 1-15. Note that researchers who previously submitted proposals for FY2008 Peer Reviewed Medical Research Program (PRMRP) funding can submit research proposals to the new program, especially if it responds to the DRMRP needs. Please be aware, however, that you cannot simply submit the same proposal for the same project to the two programs.
NAEVR Advocacy Manager David Epstein has met with the CDMRP program managers and can respond to any questions at firstname.lastname@example.org or 240-221-2902. Earlier this week, Epstein attended the Third Biennial Vision Research Symposium on Traumatic Eye and Brain Injury at the Schepens Eye Research Institute.
More information on the DRMRP is available here.